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ABSTRACT 
 
The current thesis is structured in four parts.  Vector smoothing methods are used to 
study environmental data, in particular records of extreme precipitation, the models 
utilized belong to the vector generalized additive class.  In the statistical analysis of 
observational studies the identification and adjustment for prognostic factors is an 
important component of the analysis; employing flexible statistical methods to identify 
and characterize the effect of potential prognostic factors in a clinical trial, namely 
“generalized additive models”, presents an alternative to the traditional linear statistical 
model.  The classes of models for which the methodology gives generalized additive 
extensions include grouped survival data from the Surveillance, Epidemiology, and End 
Results tumors of the brain and the central nervous system database; we are employing 
piecewise linear functions of the covariates to characterize the survival experienced by 
the population.  Finally, both descriptive and analytical methods are utilized to study 
incidence rates and tumor sizes associated with the disease. 
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CHAPTER 1: REVIEW OF THE PRESENT STUDIES 
 
In this Chapter we introduce the rest of the dissertation thesis.  We will be 
presenting its most basic features, make essential connections between different 
methodologies that are put into use, finally discuss the structure of the manuscript.  This 
chapter is formatted in one section. 
 
1.1 Introduction 
 
The first part of this section follows the exposition found in “Multivariate adaptive 
regression splines” by Jerome H. Friedman (1991).  A problem usually scientists from 
different disciplines face involves an adequate approximation of a function of several 
variables (commonly it is perturbed by noise) when only the values of the function at 
various points in the dependant variable space are given.  In applied mathematics this 
kind of problems led, to name a few examples, to the development of the multivariate 
function approximation theory, in statistics to the development of non-parametric 
regression modeling, in computer science and engineering to statistical learning neural 
networks. 
In general, the system that generates the data is described as 
. 
The deterministic single valued function  captures the relationship between the 
response  and the independent variables given the realization .  The additive 
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stochastic component , whose expected value is defined to be zero, usually accounts the 
dependence of  on quantities other than  that we cannot control or observe.  The 
goal of regression analysis is to construct a function  that will serve as a 
reasonable approximation to  over the domain of interest. 
 In the following paragraphs we will provide a brief overview of some of the 
existing methodologies.  The intention is to highlight some of the difficulties associated 
with each one of them in order to motivate the procedures that have been used in this 
dissertation. 
 In low dimensional settings (n<3) the global parametric procedure described 
above has been generalized using three interrelated paradigms.  The basic idea of this 
type of fitting is to approximate  by several functions each one defined over a different 
sub region of the domain.  The approximation is constrained to be everywhere 
continuous, or sometimes having continuous low dimensional derivatives as well.  The 
tradeoff between smoothness and flexibility of the approximation  is controlled both by 
the number of sub regions (knots) and the lowest order derivative allowed to be 
discontinuous at the sub regions boundaries.  The most popular such procedure is that 
based on splines, the functions are allowed to be polynomials of degree q with derivatives 
up to degree q-1 required to be continuous (q=3 is the most usual case).  This procedure 
is implemented by constructing a set of basis function that span the space of the qth order 
spline approximations and fitting the coefficients of the basis functions by ordinary least 
squares.  See (De Boor, 1978) for a general review on splines and Shumacker (1976, 
1984) for of two-dimensional extensions.   
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 The direct expansion to higher dimensions is straightforward in principle, but 
difficult in practice.  These difficulties are related to the so called “curse of 
dimensionality” a phrase coined in (Bellman, 1961) to express the fact that exponentially 
increasing numbers of data points are needed to populate Euclidean spaces of higher 
dimensions.  Unlike global parametric approximation, here the parameter values are in 
general different at each evaluation point and are obtained by locally weighted least-
squares fitting.  The weight function is chosen to place the dominant mass in points that 
are close to the evaluation point.  The simple constant case for the weight has been 
studied in (Parzen, 1964) and in (Shepard, 1964).  In (Cleveland, 1979) it is suggested 
that local linear fitting procedures are producing superior results, especially near the 
edges and in (Cleveland & Delvin, Locally weighted regression: An approach to 
regression analysis and local fitting, 1988) it is suggested that quadratic functions 
produce superior fit.  The difficulty with applying local parametric methods lies with the 
choice of the appropriate weight function for the problem at hand.  
 In the case of piecewise polynomials (splines) the solution is obtained as a global 
least-squares fit of the response y on the union of all basis functions (Stone & Koo, 
1985).  We refer to (Barry, 1986) and (Wahba, 1986) as well as (Chen, Gu, & Wahba, 
1989) for more insight in interaction splines.  Chapters 2, 3 and 4 of this dissertation are 
implementing the procedures based on the previous considerations for various data.  In 
the case of Chapter 2 the data comes from an environmental variable, the precipitation 
occurring over the course of several years in meteorological stations.  In the case of 
Chapter 3 these procedures are implemented to analyze data from a breast cancer clinical 
trial and finally in Chapter 4 these ideas are implemented in grouped survival from the 
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Surveillance Epidemiology and End Results data set of the American Cancer Society.  In 
Chapter 5 we continue with tumors of the brain and the central nervous system to deal 
with the associated incidence rates.  
 In more detail, in Chapter 2, the objective is to perform statistical analysis and 
modeling of actual precipitation data collected in 20 stations in Greece.  Although our 
analysis refers to the specific dataset, the same methodology can be applied to similar 
other environmental variables.  Firstly, we identify the probability density function (PDF) 
that best characterizes the behavior of the data, that being the Frechet PDF, a member of 
the family of the Generalized Extreme Value (GEV) family of distributions.  In addition 
to obtaining useful information, such as the expected rainfall along with its variance and 
confidence limits, we are able to cluster the stations into 7 groups that have similar 
response.  In further analysis, we introduce time dependence into the Frechet probability 
distribution by characterizing the location and scale parameters to be functions of time, 
furthermore complex covariates such as the North Atlantic Oscillation index.  This 
approach enables a more flexible and realistic model to quantify the uncertainty inherent 
into the system, and allows for more complex dependence patterns to explore the data at 
hand.  The Vector Generalized Additive Modeling (VGAM) class of models is used, a 
non-parametric counterpart of the Vector Generalized Linear Models (VGLM) of Yee 
and Hastie (2003) which encompasses a great variety of probability distributions outside 
the exponential family and allows for more than one predictor. 
 In Chapter 3, we study survival data a very active research field for many decades 
now.  Many of the commonly used models are centered around the important Cox 
regression model-its extensions and alternative forms.  We are employing the means of 
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generalized additive regression modeling to extend the scope of the classical Cox-PH 
model in order to provide flexible models for studying the effect of the prognostic factors 
on the hazard function.  Smoothing splines are used to form non-linear additive 
proportional hazards models to test the effectiveness of alternative treatments in a breast 
cancer clinical trial.  The modeling procedures described in this chapter are useful for a 
variety of reasons.  Firstly, they are very helpful in identifying a proper model for the 
data at hand, since they give a valuable insight into the behavior of the hazard function 
for various prognostic factors, thus preventing model misspecification, which can lead to 
incorrect conclusions about treatment efficacy.  Secondly, they provide information about 
the relationship of the covariates and disease risk that goes beyond the standard 
techniques.  Lastly, these methods can be used beyond modeling of prognostic factors for 
patient care or planning for future trials, into an investigative tool in a variety of settings. 
In Chapter 4, we investigate the relationship between medical improvements and 
the survival experienced by the brain tumors patient population.  It would be useful to 
find out when and how much the cancer treatment breakthroughs and early diagnosis 
have significantly improved the prognosis of brain cancer patients.  A join point model 
facilitates the identification of trends with significant change-points in survival; the main 
goal of such a model is to find out when cancer survival starts exhibiting a pattern of 
improvement.  The models are applied to grouped relative survival data for major cancer 
sites from the 'Surveillance, Epidemiology and End Results' program of the National 
Cancer Institute.  The data sets include collected information on incidence, prevalence 
and survival from specific geographic areas representing 28 percent of the US population.  
It is essential to model the trend of survival at the population level; tracing the change in 
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survival patterns over time, we can evaluate the effort in improving the survival chance 
of cancer patients.  Here, we consider incorporating a join point model into a population 
level for capturing possible changes in survival trend.  Besides treatment, survival may 
also be affected by the introduction and dissemination of new screening techniques and 
other prevention activities as we discuss in more detail. 
Lastly, in Chapter 5 we propose a study that provides a sufficiently detailed 
perspective on survival of patients diagnosed with tumors of the brain.  Brain cancers 
have attracted increased attention in recent decades because, although the survival rate 
continues to remain poor, there are several reports suggesting an increasing trend in 
incidence rates.  The bulk of this increase is reportedly due to rising incidence rates 
among the elderly and children.  To this end, we employ mainly descriptive and also 
analytical methods to characterize the incidence of brain tumors obtained from the 
National Cancer Institute’s Surveillance, Epidemiology and End Results (SEER) 
program, with incidence and survival statistics on tumors from various U.S. metropolitan 
areas and states collected since 1973 and mortality rates since 1969.  Surely, some of the 
variation exhibited in incidence rates for different sexes and histology types reflect 
improvements in diagnostic practices around this period. 
This dissertation concludes with Chapter 6, possible future directions are 
explained along with further considerations with regard to the work already presented. 
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CHAPTER 2: STATISTICAL ANALYSIS AND MODELING OF EXTREME 
PRECIPITATION DATA 
 
The primary goal of this chapter is to analyze actual precipitation data collected in 
20 meteorological stations in Greece.  Although the analysis and statistical modeling 
procedures utilize extreme precipitation data, the same methodology can be applied to 
similar climate data or other variables.  We first identify the probability density function 
(PDF) that best characterizes the behavior, the Frechet PDF, a member of the Generalized 
Extreme Value (GEV) family of distributions.  In addition to obtaining useful 
information, such as the expected rainfall along with its variance and confidence limits, 
we are able to cluster the stations into 7 groups with similar response.  We introduce time 
dependence into the distributional parameters using the Vector Generalized Additive 
Modeling (VGAM), the location and scale parameters of the PDF are dependent on time 
or other covariates, such as the North Atlantic Oscillation Index (NAO).  This approach 
enables a more flexible model that quantifies some of the uncertainty inherent into the 
system, and allows for more complex dependence patterns. The study is structured as 
follows:  In Section 1 we present useful information related to the data used in the study 
and  review some of the basic concepts of the Extreme Value Theory that are essential in 
developing the proposed statistical models.  The models are developed in the following 
section along with the supporting statistical analysis.  In Section 3 we tabulate all the 
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essential estimates and then profile and cluster the precipitation data.  Finally, we present 
the maximum likelihood estimates for the parameters of the adopted models. 
 
2.1 Background information 
 
Despite the recent interest on global warming and climate change it is useful to 
point that any significant change in either the mean state or the variability of a weather 
phenomenon persisting for a long period of time is termed as climate change.  Climate 
change is not only characterized by changes in the mean, but also changes in the 
variability and extreme and rare events, for instance precipitation, wind etc.  The rest of 
this section is organized as follows: in subsection 2.1.1 we provide the essential and 
useful information with reference to the data collection as well as identify and comment 
on some of its basic characteristics.  In subsection 2.1.2 we give the essential elements of 
the extreme value theory and review its non- stationary extension. 
 
2.1.1 Data Sets Sources and Collection 
The precipitation data were obtained from the European Climate Assessment 
project (Klein Tank et al., 2002) and consist of daily precipitation values.  The thesis of 
this organization is that increasing the knowledge of past changes through analysis of 
historical records of observations is relevant to climate research for the interpretation of 
future trends and changes.  The relative sparseness of long available records of daily 
values of climate parameters in other regions of the word hampering analyses, is not an 
issue for the European continent, which is one of the most data rich regions.  In general 
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though precipitation changes have been less coherent than temperature changes.  We 
tabulate some of the stations’ information about chronologies along with elevations 
below and refer to Figure 2.1 for other geographical characteristics.  The periods shown 
in the table are similar for the other stations, except for the case of a station in Athens that 
includes data since the beginning of the 20th century.  
 
Table 2.1 The eight weather stations. 
Meteorological stations are widespread in the Greek peninsula and the islands, we list eight of them along 
with basic geography markers.  The stations can be located in Figure 2.1. 
Location Corfu Hellinikon Heraklion Larissa Methoni Chania Souda Argostoli 
Period  55-07 55-07 55-07 55-07 56-07 58-07 58-07 58-00 
Elevation(m) 11 15 39 73 52 151 146 22 
 
In the map below we point at the precipitation stations where data was collected.  
Greece is located at the southeastern extreme of the European continent bordering both 
the African and the Asian regions. 
 
Figure 2.1 Map of Greece indicating the meteorological stations. 
The geographic disparities of the stations play a significant role in the analysis. 
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In Figure 2.2 we depict the annual maximum daily precipitation from 1900 to 
2002 measured at the meteorological located in the heart of Athens.  The variation 
appears to exhibit some kind of non-stationary features; one of our goals is to study this 
and explain some of the features that are present in the data.  The temporal variability and 
its possible directions believed inherent in the system has not been studied according to 
our knowledge. For further insight on the stationarity hypothesis we refer to (Nogaj, 
Parey, & Dacunha-Castelle, 2007), (Katz & Brown, 1992) and (Ferro, Hannachi, & 
Stephenson, 2005). 
 
 
Figure 2.2 Annual maximum daily precipitation recorded in Athens, Greece. 
A scatter diagram obtained from the longest standing weather station with data covering the previous 
century 103 years in total. 
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However, this variability can also be explained by an environmental covariate or 
index a function of time, the framework we are using can support such attempts along 
with predictions based on extrapolations.  We have used the North Atlantic Oscillation 
index, monthly values of which were obtained by the National Oceanic and Atmospheric 
(NOA) climate prediction center and averaged annually.  The North Atlantic Oscillation 
index measures the difference of mean atmospheric sea level pressures roughly between 
Azores and Iceland and serves as a measure of meteorological volatility.  It is believed 
that negative values of this index give wet weather in the Mediterranean. 
 
2.1.2 The Generalized Extreme Value Distribution and its Extensions. 
There is a growing interest in the use of statistical methodologies for analysis and 
prediction of rare events.  In the standard methodology for modeling extremes of 
processes, we usually employ asymptotically motivated models for making inference and 
prediction on the basis of the adopted model.  The classical analysis is based on the 
Extreme Value Theory for the stationary case, obtaining values for the parameters of the 
probability distribution of extremes.  However, in this chapter we would like to stress a 
different aspect of this paradigm that does not involve the assumption of a stationary 
model, which may lead to poor assessment of the uncertainty of an extreme value event.  
We begin by reviewing essential aspects of the extreme value theory.  The 
extremal types theorem- as suggested in (Fisher & Tippett, 1928) identifies three distinct 
types of behavior combined into a unified parametric family, actually the value of one the 
parameters determines the type of the probability distribution.  Let  be a series of 
independent and identically distributed random variables with common cumulative 
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probability distribution function F, and .  Suppose that there exist 
sequences of normalizing constants  and , such that, as  
 
for all , where  is a non-degenerate probability distribution function.  So, for a 
single process the behavior of the maxima can be described by one of the three extreme 
value probability distributions: Gumbel (known also as double exponential), Frechet and 
negative Weibull.  The Generalized Extreme Value Distribution (GEV) developed in 
(Jenkinson, 1955) is a family of continuous probability distributions consisting of the 
Gumbel, Frechet, negative Weibull families, also known as, type I, II, and III extreme 
value distributions with cumulative probability distribution function given by  
 
where ,  and  are the location, scale and shape parameters, respectively.  The 
particular case  of the previous equation results to  
 
 
the Gumbel probability distribution also known as the extreme value-double exponential 
PDF, while in cases when  and  result into the Frechet and the negative 
Weibull probability distributions, respectively.  
 Each of the three types of probability distributions has distinct forms of behavior 
in the tails.  The Weibull is bounded above, meaning that there is a finite value that the 
maximum cannot exceed.  The Gumbel probability distribution yields a light tail, 
meaning that although the maximum can take on infinitely high values, the probability of 
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obtaining them becomes small exponentially.  The Frechet, a heavy tailed distribution, 
decays polynomially so that higher values of the maximum are obtained with greater 
probability than would be the case with the lighter tail.  Through statistical goodness-of-
fit procedures we can identify which of the family of extreme value probability 
distributions best characterizes the rainfall data.  In the case of the rainfall data, usually 
the Frechet probability distribution is adequate.  For further insight we refer to (Hosking, 
Wallis, & Wood, 1985) and (Galambos, 1987). 
 The classical statistical analysis is based on the assumption that the cumulative 
probability distribution  of the observed data  does not vary over time.  Results 
obtained using maximum likelihood estimation can be seen in Section 4.  When modeling 
annual maxima  during the calendar year j by employing the generalized extreme 
value distribution and inducing variation in the parameters from year to year, we are 
assuming independent variables with a non-stationary GEV distribution given by: 
 
We will consider the shape parameter ξ time invariant.  The stationarity hypothesis 
for the particular parameter is supported by studies involving estimation over different 
time periods of long climatic time series (Parey, Laurent, & Dacunch-Castelle, 2007).  
Moreover, estimation is numerically fraught if this parameter is allowed to vary and the 
instability is intensified in case of scarcity of information.  In general, the shape 
parameter is considered to be the main one describing the behavior of the probability 
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distribution at extreme levels; therefore, a varying ξ would induce significant variation in 
the underlying process (Embrechts, Kluppelberg, & Micosch, 1997).  Note that, for ξ>0.5 
maximum likelihood estimation is regular, and that, for -1<ξ<-0.5 maximum likelihood 
estimators exist but are non-regular, whereas, for ξ< -1 maximum likelihood estimation 
fails because it corresponds to short tailed distributions (Smith, 1985). 
 
2.2 Vector Generalized Additive Statistical Models 
 
In this section we review in short the basic components of the Vector Generalized 
Additive Models (VGAM) and vector splines.  The subject models are a non-parametric 
extension of the Generalized Linear Models (GLM) and constitute a data-driven approach 
for analysis and statistical inference.  The GLM class fits models from the exponential 
family and one extension developed in (Yee & Wild, Vector generalized additive models, 
1996) encompasses different statistical probability distributions by using vector splines or 
vector smoothers a generalization of the cubic spline, see (Fessler, 1991) and Iteratively 
Reweighted Least Squares (IRLS) methods to fit them.  
Since the methods of this chapter depend critically on vector splines we begin by 
a short introduction following the lines of “Vector generalized additive models” by T. W. 
Yee and C. J. Wild (1996).  We refer to the following as a vector measurement 
model: , ’s are independent with  and 
 known symmetric, positive definite error covariance matrix.  The above 
statistical model can be used for developing a scatter plot of the data  where the 
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fitted vector of smooth functions  (Yee & Hastie, Reduced-rank 
vector generalized linear models, 2003), are estimated by minimizing the quantity 
 
where the lower and upper limit in the previous integral are less and greater than the 
observed values ’s.  The symbol  in the previous expression is used for the transpose 
of a matrix. 
 The first term in the above quantity comprises a standard measure of goodness-of-
fit to the data (average residual sum of squares), while the second term induces a natural 
measure of smoothness associated with a function.  The parameters  define the tradeoff 
between smoothness and goodness-of-fit and are referred to as smoothing parameters.  
When ’s are large, a premium is placed on smoothness, conversely small values of ’s 
correspond to more emphasis on goodness-of-fit.  From a practical point of view, the 
smoothness of a spline can be more easily controlled by specifying the degrees of 
freedom of the smooth than defining a value for .  Thus, usually one first specifies the 
associated degrees of freedom and the values of the smoothing parameters are then 
computed to correspond to the desired smoothness.  
 We continue with the description of the fundamental aspects of Vector 
Generalized Additive Models (VGAM).  The VGAM class, a non-parametric counterpart 
for the vector generalized linear models (Yee & Hastie, Reduced-rank vector generalized 
linear models, 2003) encompasses a great variety of probability distributions outside the 
exponential family and allows for more than one predictor.  Generalized linear models 
(GLM) were introduced in (Nedler & Wedderburn, 1972), the response variable y can be 
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characterized by a probability density from the exponential family of distributions and the 
true mean response µ of the random variable y is regressed to a p-vector of covariates, 
 according to the following statistical model: 
 
where . A non-parametric extension to naturally occurring non-linear 
statistical models was given by (Hastie & Tibshirani, 1987, 1990), namely the class of 
generalized additive models (GAM) allowing the response to be modeled as follows: 
 
 where  denotes an arbitrary smooth function estimated using a local scoring algorithm.  
This data-driven approach allows non-linear features of the available information to be 
studied in a straightforward way, without the use of variable transformations.  
 Yee and Wild introduce the method used in 1996 building upon the GAM 
foundation allowing the response variable y to be a vector.  Suppose that the observed 
response y is a q dimensional vector, a vector generalized additive model (VGAM) is 
defined by 
 
‘s are now sums of smooth functions of the individual covariates plus an intercept 
term.  As in (Yu, Huang, Tiwari, Feuer, & Johnson, 2009) for the case of generalized 
additive models, the  ‘s are fitted using smoothers (the word smoother refers to the 
mathematical tool used to smooth a scatter plot) estimated simultaneously by an 
iteratively reweighted least squares (IRLS) algorithm (Green, 1984).  Note also that the 
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estimation involves centering the smooth functions of the individual covariates for 
uniqueness. 
 Some of the advantages of vector generalized models are that they allow the 
predictors  to be applied directly to the parameters of a probability distribution rather 
than to their means as with the generalized linear models, and can embrace a broad range 
of statistical models which include the bivariate logistic (McCullagh & Nedler, 1989), 
beta distribution, the negative binomial, as well as the extreme value family of 
probability distributions.  They allow a visual data-driven approach to the phenomenon 
and the interpretation is based on the additive nature of the model. 
 
2.3 Discussion of the Results 
 
We shall assess how the extremes depend on the temporal scale (year) and the 
North Atlantic Oscillation index (NAO), for the case of Corfu (location No55), 
containing 53 annual measurements from 1955 to 2007, and two variables, namely year 
and NAO representing the year and the annual mean value of the NAO index.  An initial 
GEV VGAM model was fitted giving a nominal three degrees to the year “smoother” and 
two degrees of freedom to the NAO “smoother” since it serves as a proxy, moreover 
three degrees of freedom would not serve the numerical stability of the model.  The shape 
parameter was fitted as an intercept only term for the previously described reasons.  The 
model is represented by the following equations: 
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where y denotes the year and s denotes the NAO index.  Figure 2.3 shows the fitted 
functions , , ,  from the above model.  Both the location 
and scale parameters exhibit a convex behavior with respect to time (see two upper 
graphs) and seem to reach their lowest levels between the years 1980 to 1990.  For the 
effect of the North Atlantic oscillation index, the two graphs at the bottom strongly 
support the argument of an effect in extreme precipitation in case of negative values of 
the NAO index as shown in the behavior of the location parameter (left).  Furthermore, 
for negative values of the NAO index the effect on the scale parameter (right) is negative 
resulting in smaller range of possible values for the extreme precipitation. 
 
 
Figure 2.3  Initial model predictions for the Corfu data. 
Plots of the smoothers fitted to the annual maximum precipitation values between 1955 and 2007. The 
model estimates presented here quantify uncertainty in the generalized extreme value distribution 
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parameters associating with the annual NAO index values and the calendar year. From top left to bottom 
right the fitted functions as in the equations of the previous section, resulting in a location y coordinate for 
the left column and a scale for the right column.  The dotted lines represent ±2 standard error bands. 
 
These kinds of plots are by nature wider at the boundaries since less data is available 
there. The estimate (intercept) of ξ was 0.108 with dominating standard error of 0.103, 
which would indicate a Frechet-type density and is in agreement with the estimate of a 
stationary GEV model (0.176 with standard error of 0.111).  The results suggest that the 
two fitted functions related to the NAO index are linear.  For the sake of computational 
efficiency and stability, we will assign one degree of freedom to the remaining functions, 
but model the function  which appears to be L-shaped as a piecewise linear 
regression spline due to the smaller predicted location value around the year 1990.  We 
suggest the model depicted in Figure 2.4, where three functions are linear and the smooth 
function  is piecewise linear, experiencing an increase in deviance of 1.074 for a 
decrease in the degrees of freedom of 5.  A likelihood ratio test would therefore yield a p-
value of .  We refer to (Buja, Hastie, & Tibsirani, 1989) and (Hastie 
& Tibshirani, 1990) for matters pertinent to the effective degrees of freedom in a VGAM 
model. 
 We point out that the scale parameter, in contrast to the location parameter, has 
not significantly varied for the period of study, as well as that negative values of the 
NAO index have indeed contributed into a positive shift of the location parameter for the 
proposed distribution. 
 
 20 
 
Figure 2.4 Piecewise linear model predictions for the Corfu data. 
A more parsimonious model fitted to the Corfu data, the smoothers are shown in the same order as in 
Figure 2.3.  The 2 standard error bands intersect at the sample mean of the covariates. 
 
Results from fitting data from other meteorological stations and the results are 
presented in short in the following two paragraphs. 
 Utilizing the introduced methodology we developed models for different stations.  
Those situated at Methoni and Hellinikon exhibit a concave down behavior peaking 
during the period 1970-1995 (the peak for Methoni precedes Hellinikon in 1990 by about 
five years) for both the location and the scale parameters.  The model proposes a concave 
up behavior for the scale parameter preceding the 1970 to the present behavior.  We 
present the modeled behavior for the Hellinikon station in Figure 4.3 below, since it is in 
that general area (Athens metropolitan area) that almost 40% of the Greek population 
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lives.  The graphs depict the behavior of the location (left) and scale (right) parameters 
using year (upper) and NAO (bottom) covariates.  We will refer to the NAO findings at 
the end of this study. 
 
 
Figure 2.5 Spline predictions for the Hellinikon station. 
The predictions for the covariate effects using the same analytical structure for the model for the Hellinikon 
station data.  
 
We believe that for some of the remaining stations (Heraklion, Larissa, Argostoli, 
Souda, Chania) the linear trends depicted by the models do not suggest any significant 
temporal variation of the parameters of interest, since the standard errors of the non-
parametric regression slope coefficients when computed and were found to be 
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considerably large.  Having said that, we would favor a stationary GEV model against a 
non-stationary for the specific stations.  
 Once the best model for the data has been determined, it is of great importance to 
derive the return levels of the phenomenon of interest.  For the GEV distribution 
described before, the T year return level is the level exceeded on average only once in T 
years.  This kind of modeling of environmental processes is standard practice for the 
design in civil engineering for example.  Using historical data, estimates of design 
parameters are required which would lead to the construction having a specified low level 
failure probability.  For that respect in many environmental processes, estimates of the 
probability of events that are rarer than those already recorded are often required.  For the 
stationary Frechet and negative Weibull models it is attained by  
 
 
by inverting the expression .  Figure 2.6 depicts the return levels under the 
proposed models for up to 100 years when an intercept-only model is assumed for eight 
of the locations that we believe the data is sufficiently dense to give us reliable results.  
On this plotting scale the relationship is linear for the Gumbel type , with positive 
(negative) curvature for , .  By visual inspection of similar graphs we were 
able to gain some insight for the mean annual maximum precipitation behavior and 
postulate about possible equalities in the mean behavior for the different locations. 
Having done so, we formally tested for the pair-wise equality of means using the 
Anderson Darling non-parametric test for the equality of mean extreme precipitation and 
then proceed to test for equality between three or more locations. 
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Figure 2.6 Return level plots for extreme precipitation. 
The generalized extreme value model has been applied to compute the return levels for eight of the  stations 
for a time period of one hundrend years. The Frechet or Gumbel distributions have been used for the 
calculations of the return levels shown.  
 
The results obtained at the 95% confidence level strongly reaffirm the visual 
findings obtained by over plotting the return levels in Figure 2.6 and suggest equal mean 
annual extreme precipitation for the Corfu, Rodos pair, as well as for the Argostoli, 
Chania and Souda locations.  The triplet of relatively neighboring islands Naxos, Milos, 
Kythira can be clustered together, as well as Tripoli, Kalamata, Ioannina, Mitilini, 
Agrinio which are similar in terms of expected maximum annual precipitation.  
Moreover, two distinct locations in the city of Athens, Hellinikon and Athens along with 
Heraklion form a cluster containing densely populated areas.  Another cluster of great 
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interest includes Larissa and Thessaloniki.  Finally, Methoni and Ierapetra comprise the 
last cluster at the 95% confidence level, as shown in Figure 2.7. 
 
 
Figure 2.7 Clustering of the extreme precipitation data. 
We have identified seven discrete behaviors in terms of the extreme precipitation experienced as described 
by the lines. It is important to point out that the variation exhibited permits for further study of the 
underlying factors present in different geographical areas.  
 
The maximum likelihood estimates for the parameters along with the corresponding log-
likelihoods for the seven newly formed clusters of similar extreme precipitation records 
can be found in Table 2.3 shown below.  For these estimates we have used a 
computational approach which enables non stationarity for the parameters, we restricted 
the slope coefficients to be zero and used the intercept estimate of the linear form 
invoked. 
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Table 2.2 Maximum likelihood estimates for the distributional parameters. 
The estimates provided were computed by pooling the data of the stations exhibiting similar extreme 
precipitation response data  as described in Figure 2.7. 
 
Cluster Location Scale Shape -log(Lik.) 
Larissa,Thessaloniki 33.83 (1.46) 12.51(1.17) 0.21(0.08) 393.47 
Naxos,Milos,Kythira 38.51(1.47) 13.83(1.16) 0.15(0.08) 515.65 
Hellinikon,Heraklion,Athens 39.21(1.08) 13.87(0.84) 0.14(0.05) 897.42 
Methoni,Ierapetra 44.89(1.70) 14.61(1.45) 0.32(0.08) 409.52 
Tripoli, Kalamata Ioannina, Mitilini,Agrinio 54.24(1.33) 17.07(0.96) 0.05(0.04) 888.73 
Argostoli, Chania, Souda 50.84(2.03) 21.66(1.63) 0.20(0.07) 725.20 
Corfu, Rodos 68.15(2.84) 24.08(2.20) 0.14(0.08) 450.37 
 
2.4 Conclusions 
 
This study exhibits how a class of statistical models, namely, the Generalized 
Extreme Value class of distributions can be fitted to precipitation data. The case for using 
those models is made in two stages.  The first is the classical analysis, fitting models with 
stationary parameters for the chosen distribution.  An important feature of this approach 
is its simplicity that makes it attractive to non-statisticians and allows easy interpretation 
of return levels and return periods, which are extremely useful in engineering, agriculture 
and even meteorology.  We believe that the process of fitting and using the models and 
producing plots can be made into a routine that is readily usable. 
 The major limitation of this type of analysis of precipitation, is insufficient use of 
the data so that long records are required if we are to obtain estimates having reasonably 
small standard errors.  The literature gives alternative methods that try to overcome this 
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weakness, the most popular being the peaks-over-threshold approach for the extreme 
values.  One problem with the latter method is that it makes more assumptions about the 
structure of the data. 
 The second case for using these kinds of models includes the use of the class of 
Vector Generalized Additive models that offer significant advantages for extreme value 
data analysis, since they allow parameters of distributions associated with extreme value 
theory originally modeled as fixed scalar, to be modeled as smooth functions of 
covariates.  In general statistical analysis, smoothing allows for a data driven approach 
rather than a model driven approach, so that the data can speak for itself.  In our analysis 
we identified several types of non-stationarity and modeled the behavior of the longest 
record available.  
 We also discussed here some spatial aspects of the precipitation data available.  
Thought this is a large and complex field, the modeling approach we followed should be 
useful when analyzing several related sites as when looking at just one.  The models at 
different sites may be compared directly or used to derive distributions of interest at each 
site are then compared. 
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CHAPTER 3: GENERALIZED ADDITIVE MODELING FOR SURVIVAL DATA 
FROM A BREAST CANCER CLINICAL TRIAL 
 
Survival data analysis has been a very active research field for many decades 
now.  Many of them are centered on the important Cox regression model-its extensions 
and alternative forms.  The present study is employing the means of generalized additive 
regression modeling to extend the scope of the classical Cox-PH model in order to 
provide flexible models for studying the effect of the prognostic factors on the hazard 
function.  Smoothing splines are used to predict the behavior and form non-linear 
additive proportional hazards models, in order to test the effectiveness of alternative 
treatments in a breast cancer clinical trial. 
 
3.1 Introduction 
 
Each year governments and organizations around the word fund thousands of 
clinical trials following the history of diseases and evaluating alternative treatments.  
Accurate analysis of the provided information is critical if the nature of the care for 
individuals is to be directly affected by the findings, also to save time and money.  While 
determining a treatment’s efficacy is an important goal for a clinical trial, identifying 
prognostic factors is an equally important component of the analysis.  We note that a 
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valid comparison between treatments is possible only after correctly accounting for 
factors that may affect the course of the disease. 
 Survival analysis or failure time data analysis is interested in the time  from a 
defined time origin to the occurrence of a given event.  In biomedicine the typical 
example is the time from randomization to a given treatment, until the event occurs 
leading to the observation of survival time for the patient involved.  Usually the objective 
to compare different treatment effects on the survival time while incorporating available 
information for each patient leads us to a statistical regression analysis problem.  In many 
occasions the survival times are incompletely observed, the most common example being 
right censoring, it is only known for the survival time  that it is larger than an observed 
right censoring value. 
 If the focus is non-parametric, the cumulative hazard function or the survival 
function can be estimated using the Nelson-Aalen and the Kaplan-Meier estimators, 
respectively.  The proportional hazards model is a popular semi-parametric tool for 
analyzing censored failure time data- we are using the term failure time as a generic term 
to refer to the time up to the endpoint of interest.  It is semi-parametric in the sense that it 
does not make distributional assumptions about the failure times, but on the other hand 
does specify the form in which covariates, or prognostic factors, affect the hazard rate of 
failure.  The model easily accommodates right censored data, usually the case for clinical 
trials where the patients enter at random times but whose follow-up ends at a fixed time 
point. 
 The Cox or proportional hazards regression model is on many occasions used to 
simultaneously model prognostic factors and treatment effects for the failure times 
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involved.  We briefly outline the model in the next section and incorporate tools that can 
investigate the effect of a prognostic factor, whether linear or nonlinear. 
 
3.2 Essential Theory for the Additive Models  
 
The method used, namely an additive proportional hazards model provides 
estimates of treatment effects related nonlinearly to the prognostic factors, relaxing the 
linearity assumptions and allowing smooth non-linear functions of the covariates to be 
included in the log hazard ratio.  
The advantage is that possible transformations of the variables involved are not 
chosen a priori by the analyst, but rather estimated flexibly from the data at hand.  
Another attractive feature is that the need to categorize a continuous covariate in order to 
discover the nature of its effect is alleviated.  Though there are several methods to 
accommodate the non-linear terms, the methods used here are splines; picewise 
polynomials satisfying continuity constraints at the knots joining the pieces.  See (De 
Boor, 1978),  (Eubank, 1988) and (Wabba, 1990), for a general review of splines.  
(Hastie & Tibshirani, Generalized additive models: some applications, 1987), (Hastie & 
Tibshirani, 1990), and (Gray, 1994) discuss the effect of number of knots with respect to 
sensitivity of the proposed models, as well as regression splines. 
 We start by briefly describing a few concepts in nonparametric regression; a 
smoother is a tool for summarizing the trend of a response measurement  as a function 
of one or more predictors’ measurements .  Since the smoother does not assume 
any rigid form for the dependence between and the predictors it is often referred to as a 
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tool of non-parametric regression.  In (Hastie & Tibshirani, Generalized additive models: 
some applications, 1987) the estimate produced by a smoother is called a smooth.  
Smoothers are used both for helping us pick out the trend in the relationship, and estimate 
the dependence of the mean of  on the predictors, thus serving as the building block for 
the estimation of additive models.  
 An important class of smoothers, is that of regression splines representing the fit 
as a piecewise polynomial.  The regions that define the pieces are separated by a 
sequence of knots or breakpoints .  Although many different configurations are 
possible it is a popular choice to have piecewise cubic polynomials constrained to be 
continuous and have continuous first and second derivatives at the knots.  By allowing 
more knots the family of curves becomes more flexible.  For a given set of knots, the 
smooth is computed by multiple regressions on an appropriate set of basis vectors, in this 
case piecewise cubic polynomials evaluated at the observed values of the predictor.  The 
main difficulty when working with regression splines is selecting the number and 
position of the knots. 
 
3.2.1 Penalized Least Squares  
 Unlike the regression splines mentioned before, they are not constructed 
explicitly, but instead they emerge as a solution to an optimization problem: among all 
functions  with two continuous derivatives, minimize the penalized residual sum of 
squares 
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where  is a fixed constant, and the parameter  plays the role of the smoothness 
regulator.  Large values produce smoother curves while smaller values produce more 
wiggly curves.  In an additive model with  covariates  generalizing in the 
obvious way leads to minimizing  
 
known as the penalized least squares criterion.  For a variety of justifications for the 
resulting estimating equations and the use of the backfitting algorithm as well as its 
convergence for multiple predictors see (Hastie & Tibshirani, 1990), chapters 4 and 5. 
 
3.3 The Proportional Hazards Model 
 
In this section we present the adopted models in first two subsections, and apply the 
proposed methodologies for the data which consists of 77 uncensored observations and 
564 censored observations from a breast cancer clinical trial conducted in Princess 
Margaret Hospital in the last subsection. 
 
3.3.1 Analytical Background 
 The data consist of the usual survival set up, where times , which are 
either observed survival times, or censored times and censoring indicators, with , if 
the corresponding  is an observed survival time and zero otherwise, finally p-vectors of 
fixed covariates .  Cox’s proportional hazards model interest is in the hazard 
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function, the instantaneous probability of failure for an individual at time , given that it 
has survived until then 
 
An arbitrary baseline hazard function  common for all individuals with covariate 
vector  is also assumed.  The analytical form of an additive Cox model is given by 
 
We extend the above model to a generalized additive proportional hazards model as 
follows: 
 
where  is a suitable smooth function with varying degree of smoothness. 
Of great interest always should be identifying important interactions between 
prognostic factors- this may turn out to be more significant than individual effects and 
emphasizing on the shape of the effect.  To look for possible interactions between 
continuous and categorical covariates, separate spline functions are fit for the continuous 
covariate within the levels of the categorical covariate.  A test for the hypothesis that the 
shape of the function is the same within the levels has been proposed in (Gray, 1994). 
 Examining the assumptions of the proportional hazards model has generated an 
extensive literature.  We mention (Cox, 1972), his original paper suggested fitting time 
varying covariates, and (Zucker & Karr, 1990). 
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3.3.2 Generalized Additive Statistical Models 
 Traditionally, estimation for the model is achieved by means of differentiating 
Cox’s log-partial penalized likelihood.  For the generalized additive proportional-hazards 
model alternatively 
 
where, ,  and , the partial likelihood is 
 
We denote with D the set of indices of individuals for who the event of interest has 
occurred (failure), and for each and  is the risk set at the time of the th 
occurrence, and  is the set of indices of the failures at  the observed failure time. 
 We work with the log partial likelihood , after adding a penalty term of 
the form  for each nonlinear term.  The minimization problem is solved by 
defining and  obtaining equations for the Newton-Raphson iteration 
method, though there are methods which specialize in developing local scoring 
algorithms for diagonal approximations of the matrices involved (Gauss-Seidel method). 
  The minimization criterion trades off fidelity to the data (log-partial likelihood 
component) with smoothness (penalty component).  When ’s are large, a premium is 
placed on smoothness; conversely small values of ’s correspond to more emphasis on 
goodness-of-fit.  From a practical point of view, the smoothness of a smooth can be more 
easily controlled when specifying its equivalent degrees of freedom rather than defining a 
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value for .  Thus, usually one first specifies the associated degrees of freedom and the 
values of the smoothing parameters are then computed to correspond to the desired 
smoothness.  There exist a variety of methods for identifying the appropriate resulting 
spline, see (Eubank, 1988), pp 189-195 and (Hastie & Tibshirani, Generalized additive 
models: some applications, 1987) pp 27-29.  For an automatic method using cross-
validation techniques, we refer to (Eubank, 1988) pp 220-230.  
 A penalized spline basis for the predictor is specified.  This is done by fitting a 
comparatively small set of splines and penalizing the integrated second derivative; results 
are similar to smoothing splines with a knot at each data point but computationally 
simpler.  The fitted functions can be used to suggest where non-linearities are needed, 
and if so the number and position of knots needed.  
 For hypothesis testing, statistics are available for the penalized likelihood form; as 
they would be for the ordinary parametric likelihood ratio case, see (Gray, 1994).  
Residual plots can also be used to examine possible bias in estimates for the other 
variables (Therneau, Grambsch, & Fleming, 1990), even though using flexible spline 
models should result in less bias than when using more restrictive standard models.  
Winnet and Sasieni (2001), describe situations were they may be inappropriate and give 
simple alternative guidelines for using Schoenfeld residuals. 
 
3.3.3 Application to Breast Cancer Clinical Trial Data. 
We illustrate these procedures on data from a breast cancer clinical trial.  The 
same data has been studied by (Fyles, 2004) and the conclusions include: “As compared 
with tamoxifen alone, radiotherapy plus tamoxifen significantly reduces the risk of breast 
 35 
and axillary recurrence after lumpectomy in women with small, node-negative, hormone-
receptor-positive breast cancers.”  Between 1992 and 2000, a total of 769 women 50 
years of age or older who had undergone breast- conserving surgery for an invasive 
adenocarcinoma 5cm or less in diameter (pathological stage  or ) were randomized.  
Specifically, 383 were assigned to the tamoxifen-alone arm (Tam) and 386 to the 
combined radiation and tamoxifen arm (RT+Tam).  The last follow-up was conducted in 
the summer of 2002.  Only those patients accrued at a single contributor institution are 
included here: 321 patients in the Tam arm and 320 in the RT+Tam arm.  
 The events recorded were local relapse, axillary relapse, distant relapse, second 
malignancy of any type, and death.  The time of the first occurrence of each type, of 
event was documented.  The time was calculated in years from the date of randomization 
to occurrence of the event or last follow-up date.  For the event of our study, actual 
survival time, 593 of the 641 recorded times were censored and the median follow up 
time was 5.6 years.  Table 3.1 gives a preliminary insight into the data in hand.  The 
numbers shown are counts for the respective observations.  Of the 6 types of histology, 
only two included enough patients in both treatments, so in the stratified samples there is 
little information about the effect of histology, and no attempt will be made to estimate 
this effect. 
 
Table 3.1 A contingency table for the categorical covariates. 
The numbers shown are counts for the respective observations.  Among the 6 types of histology, only two 
included several patients in both treatments, so in the stratified sample there is little information about the 
effect of histology. 
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 Histology Node dissection Hormone receptor level 
Treatment DUC LOB MED MIX MUC OTH NO YES NEG POS 
Tam 203 17 1 82 8 10 53 268 21 300 
RT+Tam 194 14 4 92 8 8 53 267 25 295 
 
The following variables were considered as potential prognostic factors for the survival 
of an individual: tumor size (cm), the histology of the tumor (Ductal, Lobular, Medullary, 
Mixed, Other), the hormone receptor level, either positive or negative, hameoglobin 
concentration in g/l, whether axillary node dissection was done, or not, finally, age in 
years; overall 5 factors.  Figure 3.1 presents histograms of the distributions of age, tumor 
size and hameoglobin concentration. 
 
 
Figure 3.1 Distributional behavior of the continuous covariates and survival 
times. 
Histograms of continuous covariates and survival times at lower right.  The distribution of the tumor sizes 
is clearly skewed in contrast with the distribution of the hameoglobin concentration. 
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The kind of treatment received which included tamoxifen only, or a combined tamoxifen 
and radiation treatment are represented in the model in order to determine their relative 
impact on survival while the effect of prognostic factors is modeled simultaneously.  In 
Table 3.2 we present some of the important measures for a number of investigative 
models fitted to the data. 
 
Table 3.2 Analysis of deviance table for the tamoxifen trial data. 
Results of a number of fitted models with twelve degrees of freedom specified for each of the 3 continuous 
covariates when fitted using smoothing splines.  The remaining terms each contributed one degree of 
freedom, except the histology covariate that contributed 5 degrees of freedom.  
 
model Deviance    
(i) null 587.42 641   
(ii) tumor size 558.93 640 28.49 1 
(iii) s(tumor size) 556.49 629 30.93 12 
(iv) histology 582.97 636 4.45 5 
(v)hormone receptor level 579.66 640 7.75 1 
(vi) hameoglobin 586.11 640 1.31 1 
(vii) s(hameoglobin) 583.88 629 3.54 12 
(viii) node dissection 585.06 640 2.36 1 
(ix) age 579.39 640 8.03 1 
(x) s(age) 573.20 629 14.22 12 
(xi) tumor size + hrlevel + s(age) 542.66 627 44.76 14 
(xii) full model 539.88 620 47.54 21 
 
 A model that includes all 5 potential prognostic factors as well as possible 
treatment effects is examined using generalized additive modeling.  Twelve degrees of 
freedom were specified for each of the 3 continuous covariates fitted with smoothing 
splines.  The remaining terms each contributed one degree of freedom, except the 
histology covariate that contributed 5 degrees of freedom. 
In the presence of the 5 predictors, the effectiveness of tamoxifen plus radiation 
arm is smaller than that of tamoxifen only, (estimated hazard ratio 1.27, 95% confidence 
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interval 0.43-1.40), though the kind of treatment is not found to significantly change the 
risk of death (overall p-value 0.46).  Axillary node dissection does not significantly 
decrease the survival time (p-value 0.8) according to the data. 
 Two of the continuous covariates are linearly associated with the risk of death as 
shown in Figure 3.2: tumor size ( ) and age ( ), whose effect is linear 
(p=0.16) for the test with null hypothesis of linearity).  The log hazard ratio as a function 
of hameoglobin concentration is roughly a U-shaped function: risk decreases for 
concentrations of 100-125 g/l, is similar for concentrations between 125 and 150 g/l and 
increases thereafter.  However, the standard error term is considerably large reflecting the 
small number of women with high or low hameoglobin concentration resulting in a p-
value greater than 0.1, which is why the particular covariate is not identified as a 
significant predictor even in the linear analysis (it is clear that the best fitting straight line 
for this relationship would have zero slope).  Linearity always remains a special case.  
Thus such relationships can be easily depicted with the use of flexible modeling of 
covariate effects.  
In some instances however, spline fits can suggest an even simpler but more 
efficient, lower dimensional transformation to accurately model the behavior.  The spline 
fit for age suggests a log transformation; that is the log hazard ratio is roughly related to 
the log of the patient age.  On the other hand, a threshold effect is suggested with respect 
to the hameoglobin concentration: risk decreases for concentrations up to 130 and 
remains fairly constant for larger concentrations, the data suggests there are three groups 
of interest: the two extremes and the interior.  The increasing risk at the last region may 
be the result of patients having unusual short disease free survival times. 
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Figure 3.2 Flexible modeling of covariate effects. 
Function plots of the log hazard ratio for three single term models.  Each curve is centered to have  average 
zero over the range of data 
 
 The GAM smoothing spline fits concerning the same prognostic factors for two 
subpopulations, namely, patients in the tamoxifen-alone arm (Tam) and patients in the 
combined radiation tamoxifen arm (RT+Tam), are shown in Table 3.3 (numerical results 
concerning the combined treatment patients are underlined).  Findings are approximately 
the same with those of the previously mentioned model, the difference being that the 
effect of age in the log-hazards ratio seems to be non-linear in the single treatment case.  
We point out that some of the randomized patients were not included in the analysis, in 
case they were not accrued in a single contributor institution. 
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Table 3.3 GAM for the two subpopulations. 
Significant likelihood ratio tests p-values (<0.05) are noted with a star.  Findings are approximately the 
same with those of the previously mentioned model, the difference is that the effect of age in the log-
hazards ratio seems to be non-linear.  Results concerning the combined treatment patients are underlined. 
 
Prognostic factor Hazard ratio DF Overall p-value Non-linearity p-
value 
Linear terms     
2.48 8.7e-05* Tumor size 2.04 1 0.0014* - 
0.85  0.83 Positive hormone 
receptor level 0.42 0.12 - 
Non-linear terms  1   
0.51 0.029* Age - 12 0.0019* 0.63 
 
 The second part of our analysis also involves identifying important interactions 
among the prognostic factors in terms of the resulting hazard ratio.  It is often the case 
that the contribution of a covariate is not significant by itself, but only in cooperation 
with a particular of the remaining explanatory variables.  We identified significant 
contribution to the log hazard ratio when interaction between age and type of treatment 
was considered.  Specifically, for the combined treatment case it seems that the hazard 
ratio provided a fixed age for the patient is slightly greater for the combined radiation 
plus tamoxifen treatment (estimated hazard ratio 1.07, 95% confidence interval 1-1.15, p-
value equal to 0.04). 
 It is the conclusion of our analysis that in the presence of the given predictors 
treatment did not significantly reduce the risk of death.  The effectiveness of tamoxifen 
plus radiation arm did not differ from that of tamoxifen only.  To illustrate this point we 
fitted the Cox regression model (xi) described in Table 3.2 and compared the resulting 
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survival curves for the two subpopulations in Figure 3.3(c).  In Figures 3.3(a) and 3.3(b) 
we fitted the standard regression models and compared semiparametric survival 
predictions for the subpopulations non-parametric ones (Kaplan-Meier curves).  We note 
the constant relative risk characterization is not always consistent with the data, 
especially for the single treatment case.  These predictions would better describe the 
mortality pattern, were they based on a hazard model with time varying effects for the 
prognostic factors. 
 
 
Figure 3.3 Comparisons with non-parametric models. 
In both plots (a) and (b) above we fitted the standard regression models and compared the survival 
predictions with those based on a completely non-parametric modeling (Kaplan-Meier curves).  Survival 
predictions based on the selected additive models in (c). 
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 Turning to the categorical-continuous interactions, there is strong evidence that 
the effects of hameoglobin concentration are different depending on whether node 
dissection has been performed or not.  Figure 4.4 shows log hazard ratio estimates for 
hameoglobing, separately for the two groups.  The effect of hameoglobin concentration 
appears substantially strong in the no-dissection group, whereas it does not appear to be 
significant in the other group.  The spline fit for hgb suggests a sharp decrease in risk for 
high hgb concentrations in the particular group.  Those results have been confirmed by 
linear fits for the concentration, where only in the no-dissection group had a significant 
effect. 
 
 
Figure 3.4 Interactions between categorical and continuous variables. 
The effect of hameoglobin concentration within node dissection groups (no dissection group on the left).  
The spline fit for hgb suggests a sharp decrease in risk for high hgb concentrations in the particular group.  
Significant contribution to the log hazard ratio was identified when interactions between age and type of 
treatment were considered. 
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Again, here the spline estimates provide a useful summary of the information in the data 
beyond the given by the test results by any of the models.  The effect of the age of the 
individual was less significant. 
 
3.4 Conclusions 
 
The modeling procedures described are useful for a variety of reasons.  Firstly, they 
are very helpful in identifying a proper model for the data at hand, since they give a 
valuable insight into the behavior of the hazard function for various prognostic factors, 
thus preventing model misspecification, which can lead to incorrect conclusions about 
treatment efficacy.  Secondly, they provide information about the relationship of the 
covariates and disease risk that goes beyond the standard techniques.  For example, we 
found that it is because of the U shaped function that the best fitting line for the 
hameoglobin concentration relationship would have zero slopes, which is why it was not 
identified as a significant predictor in the linear analysis.  We should stress that linearity 
remains a special case and thus linear relationships can be easily confirmed with flexible 
modeling, as it was the case for the effect of tumor size.  Lastly, these methods can be 
used beyond modeling of prognostic factors for patient care or planning for future trials, 
into an investigative tool in a variety of settings.  
 A different approach to flexible survival analysis, the regression tree approach 
(Segal, 1988), focuses on identifying subgroups of individuals with respect to survival 
times.  The two approaches are somewhat complementary in that the additive model 
seeks for smooth main effects, while the regression tree structured technique is designed 
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to detect interactions between variables.  In (Cong & Tsokos, 2010) there is an 
investigation of decision tree issues for relapse times in the same trial, a comparison 
between these two methods would be an interesting topic for further study. 
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CHAPTER 4: TRENDS IN SURVIVAL OF BRAIN TUMOR PATIENTS IN USA  
 
In studying trend data, join point and more general spline models have been used 
to model the progress of cancer rates, and not only provide the varying trend information, 
but also indicate the time points at which the measures experience a significant change.  
Join point models have been used for incidence data, as well as mortality rates (Kim, Fay, 
Feuer, & Midthune, 2000), (Ries, et al., 2006).  However, analyzing cancer incidence and 
mortality is not always enough to understand the benefits of medical breakthroughs in 
cancer, as it does not provide information on the situation of the patients during their 
lifetime after diagnosis.  In this study we will focus our attention in modeling trends in 
brain cancer survival by introducing join points following the calendar time of diagnosis 
using the Surveillance, Epidemiology and End Results (SEER) data sets.  The data sets 
include collected information on incidence, prevalence and survival from specific 
geographic areas representing 28 percent of the US population.  This Chapter is 
organized as follows: in section 2 the relevant models and procedures are introduced.  In 
Section 3, we perform the study by presenting the models and as suggested in 
(Rosenberg, 1995) the performance of medical breakthroughs in brain cancer survival 
data.  Section 4 includes discussion and future research problems. 
 
4.1 Introduction  
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It is essential to model the trend of survival at the population level; tracing the 
change in survival patterns over time, we can evaluate the effort in improving the 
survival chance of cancer patients.  Here, we consider incorporating a joinpoint model 
into a population level for capturing possible changes in survival trend.  Besides 
treatment, survival may also be affected by the introduction and dissemination of new 
screening techniques and other prevention activities.  
 
4.1.1 Analytical Background 
If  is the calendar time and  is the survival time, defined as the time from 
diagnosis to death, we assume that the hazard rate of dying at time  follows a 
proportional hazards model with  
 
where  is the baseline hazard and  
 
will indicate the trend in survival with respect to calendar year of diagnosis .  Here 
 if  and 0 otherwise,  will be a vector of other covariates, e.g. race, sex.  
The ’s are called joinpoints because the hazard function  has different slopes 
before and after the joinpoints while continuous.  Under this formulation there are a total 
of (K+1) segments, and for the th segment the slope coefficient is 
.  In summary, the baseline hazard is dependent only 
on  the survival time after diagnosis, while the hazard function is conditional on , . 
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For the SEER survival data, the survival times after diagnosis are grouped into intervals, 
, where , and is the end of the follow up.  In that 
case the hazard rate during the interval  given that the patient is alive at the beginning 
of the interval is 
 
where  denotes the survival probability past interval  for an individual 
diagnosed on calendar year x. 
 
4.1.2 Estimation 
Consider the proportional hazard model, , where  is the 
baseline survival function, and note that 
. 
Denote .  Then it is straightforward that the baseline survival 
function can be expressed as  . 
 Under the following assumptions, and no joinpoint for the hazard function, thus 
 we have  and the quantity [ -1] 100% can be 
interpreted as the annual percent change (APC) of the hazard rate , for the diagnosis 
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year .  Accordingly, when  is defined with join points, the annual percent change of 
the hazard rate in the th segment will be given by [ -1] 100%. 
 Yu, Huang, Tiwari, Feuer, & Johnson in 2009 described the above model in detail 
and the previous follow in the lines of their paper, while several authors have either 
introduced time dependent functions (Rosenberg, 1995), or discontinuous change points 
(Lim, Sun, & Mathews, 2002) for the baseline hazard.  In this study we model the 
survival trend by fitting join points into the calendar years covariate following cancer 
diagnosis. 
 
4.2 Inference on Join Point Models with SEER Data. 
 
To investigate the relationship between medical improvements and the survival 
experienced by the patient population we are employing “join point models” in order to 
find out when and how much the prognosis for brain cancer patients has changed.  There 
are many individual studies that suggest that cancer treatments and methods of diagnosis 
improved the prognosis of cancer patients. 
 
4.2.1 Grouped Survival Data 
Survival statistics are typically expressed as the proportion of patients alive at 
some point after diagnosis.  In order to measure the excess mortality due to the cancer of 
interest, we would eliminate the confounding effects of death from other causes.  Relative 
survival is an estimate of the percentage of patients who would be expected to survive the 
effects of their cancer defined as the observed survival proportion divided by the 
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expected survival rate of a comparable population who is assumed to be free of the 
disease of interest. 
  For relative survival the cause of death is not used, the adjusted number of 
person-years at risk , by the actuarial assumption (Gail, 1975) is , for the 
patient cohort diagnosed with cancer in the year  where  is the number of people 
alive at the interval , and  is the number of patients lost to follow up during the same 
interval.  We will also be assuming the number of patients dying from all causes,  and 
the expected probability of surviving interval  for the general population .  
Usually,  will follow a binomial distribution 
, 
 or in cases where the information is scarce the Poisson distribution.  The likelihood 
function for the relative survival will then be given as in (Yu, Huang, Tiwari, Feuer, & 
Johnson, 2009) by 
. 
We used expected life tables calculated by the National Cancer Institute (NCI) found in 
(SEER Cancer Statistics Review 1975-2007), the SEER*Stat analysis software was our 
tool for calculating the grouped survival statistics. 
 
4.2.2. Likelihood Function for the Grouped Survival Data and Model Selection 
Since in the present study the joinpoints are assumed to occur at observed data 
points, the grid search method (Lerman, 1980) will be used to find the estimates of those 
points; first the log-likelihood is maximized for fixed values of , for a given  
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the maximum value is a profile likelihood and the other associated parameters can be 
estimated by least squares for usual linear model.  Then, all possible combinations of the 
join points have been tried by grid search and the maximum likelihood estimates of the 
join points are the values that maximize the log-likelihood. 
Asymptotic results for the join point regression were proved by (Feder, 1975a), as 
well as confidence intervals for the location of the join points using the chi-squared 
distribution.  For the standard errors of the parameters and the resulting confidence 
intervals for the ’s, as well as the annual percentage changes associated we refer to 
(Feder, 1975b). 
In practice we limit the maximum number of join points to three, because we 
expect the gradual dissemination of the possible breakthroughs as well as few in number 
changes in survival.  Also we restrict so that two join points cannot be too close to each 
other and that a join point cannot occur too early or too late in the study period. 
Two basic methods for model selection are used, the Bayesian Information 
Criteria (BIC) and a permutation-test based approach, which consists of as series of 
permutation tests for .  The first one, established in (Schwarz, 
1970) and consistent when the number of true covariates does not increase with the 
sample size does not tend to over fit the true model like the Akaike Information Criteria 
(AIC).  The second one, has been developed by the NCI (http://srab.cancer.gov/joinpoint) 
for cancer incidence and mortality rates, is carried out by permuting the residuals and 
(Yu, Huang, Tiwari, Feuer, & Johnson, 2009) and can be used to pick the join point 
number.  However, it is computationally intensive for use in survival data and that makes 
BIC criteria a strong competitor (Kim, Fay, Feuer, & Midthune, 2000).  For a K-join 
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point model, where  denotes the maximum log-likelihood value for the model , we 
define , where  is the total number of follow-up years and 
 is the number of parameters under model .  If the possible values for the number 
of join points are from zero to a pre-specified number, the approach will select the model 
 with the minimum BIC as the final model.  The same methods can be used to select 
the number of join points in Bayesian models (Tiwari, Cronin, Davis, Feuer, Yu, & Chib, 
2005).  
 
4.3 Application in Tumors of the Brain and the Central Nervous System 
 
We obtained survival data for individuals diagnosed with malignant brain tumor 
from the Public-Use Database of the Surveillance, Epidemiology, and End Results 
(SEER) program of the National Cancer Institute, based on the November 2009 
submission.  For patient survival analyses, only microscopically confirmed and actively 
followed cases were included.  Patients with multiple primary tumors were excluded 
from these analyses.  For survival analyses, we divided patients into eras by year of 
diagnosis. 
The relative survival rate of patients with brain tumor was calculated by taking into 
account the expected survival of a similar cohort of the general population without the 
disease.  The relative survival rate is the ratio of the observed survival divided by the 
expected survival of a cohort of the general population possessing similar characteristics 
with respect to age, race, sex, and era of diagnosis.  In this analysis, the relative survival 
rate was calculated using SEER _ Stat 6.6.2, which derives expected survival rates for the 
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general population from life tables obtained from the National Center for Health 
Statistics. 
 
4.3.1 Characteristics of the Study Participants 
We identified 75,363 patients who met the study criteria.  The median age at 
diagnosis was 72 years.  The vast majority of patients in the study were white (67,501).  
Black patients were 4,357 and other race patients each contributed 3,508 to the study 
cohort.  The average age of diagnosis of the cancer patients changes over time as shown 
in Figure 4.1.  Particularly for the elderly population (but also for children), there has 
been controversy about whether the increasing incidence is the result of the increased 
application of improved diagnostic imaging technologies such as computerized 
tomography (CT) and magnetic resonance imaging (MRI). 
 
 
Figure 4.1 Oscillation of the average age at diagnosis with brain tumor, SEER. 
The incidence of primary malignant brain tumors among the elderly has also increased during this period. 
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Incidence rates for brain cancer are higher in men compared to women and the 
gap has been unchanged in the last 30 years as shown in Figure 4.2.  Males exhibited a 
statistically significant increased incidence over time for microscopically confirmed 
tumors, whereas females showed no significant increase.  The incidence of non-
microscopically confirmed tumors was decreasing, although this result was statistically 
significant only in females  (Jukich, McCarthy, Surawicz, Freels, & G., 2001).  Although 
some investigators have suggested that female sex hormones have a protective effect 
against brain cancer, others have suggested innate differences in the susceptibility of X 
and Y chromosomes to tumorigenic stimuli as reported in (McKinley, Michalek, 
Fenstermaker, & al, 2000). 
 
 
Figure 4.2 Oscillation of the average age at diagnosis with brain tumor by 
gender, SEER. 
The data of the previous figure is used to compute gender specific incidence rates for the US population. 
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4.3.2 Models Specifications 
We compute the net (absence of other causes of death) survival rate (Cronin & 
Feuer, 2000) as described in subsection 4.2.1, a key measure for the population to assess 
the chance of cancer survival after diagnosis till the occurrence of death due to cancer.  
Assuming that a person may survive for many more years after being diagnosed with 
cancer, information on survival rates can play an important role in planning treatment 
strategies.  In addition, differences in survival rates between defined subgroups of 
patients allow clinicians and policy makers to better target interventions. 
The survival trend may not have such a big increasing or decreasing pattern as we 
observe for incidence or mortality, but as discussed in (Feuer, Kessler, Baker, Triolo, & 
Green, 1991), rates usually improve dramatically after the introduction of an effective 
treatment, and then level off after the dissemination of the cancer treatment has been fully 
realized to the population, thus indicating a possibility of the presence of multiple 
numbers of change points in survival function. 
 The brain cancer cases were diagnosed from 1973 to 2007 with follow-up to 
2007, from the SEER 17 registries, the maximum follow-up time is 35 years.  The k-year 
actuarial survival probabilities with k=1, 2, 3, 4, 5 over the year of diagnosis, for these 
patients are presented in Figure 5.3. 
We apply our proposed models to evaluate the trend in brain cancer survival data 
obtained from the SEER program.  To avoid the accurate specification of cause of death, 
in the following, we conduct only a relative survival analysis. 
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 We apply the proposed joinpoint model with maximum number of joinpoints 
equal to three.  Our primary reason for using a maximum of three joinpoints, is that, in 
practice cancer survival trends typically do not depict too many cjanges in the overall 
trend.  In order to find the best model, we use the model selection criteria described and 
compare between models, starting with no joinpoints, k=0, and moving up to k=3 
joinpoints. 
 
Figure 4.3 Oscillation of brain tumor patients survival probabilities, SEER. 
From top to bottom; 1, 2,3,4,5 year relative survival probabilities plotted against the year of diagnosis. 
 
For each value k=0,1,2,3 two different model selection methods, namely, the permutation 
test based approach, and the BIC (Bayesian Information Criteria) are employed to assess 
the fit, we found the performance of the criteria are in general terms consistent in 
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selecting the best model.  We intend to show that covariates may affect the number of 
joinpoints. 
The response variables for the analysis of relative survival are the natural 
logarithms of age-adjusted cancer rates.  We fit the heteroscedastic/uncorrelated errors 
model were the variance of the errors depends on the time of the observation.  The grid 
search uses a grid size of 1 year and the permutation tests are based on 4500 Monte Carlo 
replicates.  Four permutation tests with Bonferroni correction were performed and an 
overall significance level of 0.05. 
 
4.3.3 Results 
Assuming uncorrelated errors for the model to brain cancer relative survival data 
we obtained p-values of 0.012 testing the null hypothesis of 0 joinpoints against the 
alternative of 4 joinpoints, 0.016 testing 1 joinpoint against 2 joinpoints and 0.016 testing 
1 joinpoint against 3 joinpoints.  Comparing these to the critical value of 0.05/2, we reject 
all three null hypotheses and therefore select the one-joinpoint model as our final model.  
Fitting the same model using BIC as our selection criteria for the bestfit model we 
concluded that it would be one with two joinpoints (one on 1989 and one on 1998).  The 
resulting estimates are shown below and reflecting on the conclusive evidence against the 
statistical significance of one of the parameters we will reject this model as our final 
candidate. 
 A Poisson error model, which departs from the normality assumption, also 
suggested the one join point model regardless of the best fit model criteria; both 
suggested the relative model as the best choice.  Figure 4 shows the observed data and the 
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final one join point at 1978 model under the uncorrelated model and below are the 
estimates of the model coefficients along with their standard errors and the results of the 
appropriate significance tests under the proposed model. 
 
 
Figure 4.4 A join point survival model for brain tumor patients in USA. 
The proposed join point line fit for the relative 12month survival rate (in %) of brain cancer patients over 
the years 1973 to 2007 along with the observed values.  On the top right, the annual percentage changes in 
survival predicted by the model during the two periods involved are shown. 
 
In an effort to test weather the temporal survival improvements were not observed 
uniformly across the two sexes we fitted individual by-sex models and compared them 
with the general model.  The results were quite encouraging about the homogeneity of the 
experienced survival improvement across different sexes, as shown in Figure 5, were the 
overall model is plotted along the male sub model.  The same results were found by the 
comparison of the other resulting pair (female- mixed). 
The plot on the left in Figure 4.5 depicts the observed data and the final three-join 
point model for the Poisson model with join points at 1977, 1992 and 1995.  On the right 
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we plot the final two-join point model under the normal errors model with join points at 
1991 and 1995.  Comparing the two models we see they are quite similar, except that the 
two-join point model predicts a slight change in trend during the 1973-1977 period. 
 
  
Figure 4.5 Alternative join point models for male and female populations in the 
USA, SEER. 
Competing models for relative survival rates estimates: Poisson uncorrelated errors model (3 join points) 
with APC printed for each line segment on the left and normal errors model (2 join points) with APC in the 
right.  Coded with zero is the general population and coded with 1 is the male population. 
 
4.4 Conclusions 
 
We followed a well-documented procedure to identify changes in trend data for 
brain cancer patients in the USA.  In the process of comparing cancer survival with 
special interest in recent years we would like to stress the following: the join points once 
identified should not become fixed as we search for additional ones in future 
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circumstances.  The procedure employed here identified the best fitting set of points over 
the entire data in hand.  There have been instances in the literature (Zhang, Sha, & Zhu, 
1995) were sequential tests were used, the join points once identified, become fixed as we 
search for additional ones.  Since the 27 years of data have already been observed, it 
seems better to analyze the overall best fit.  In future years, however, we should be 
cautious in maintaining a valid model, in the presence of repeated analysis, adding on 
additional point at a time. 
Bayesian methods as mentioned before (Tiwari, 2005) have also been applied to 
join point regression for cancer rates.  Those approaches will incorporate a prior 
distribution on the number of join points, the other regression parameters and the error 
variances.  The estimation of the marginal likelihoods based on the Markov chain Monte 
Carlo (MCMC) method, are described in (Tanner & Wong, 1987) and (Gelfand, 1990) or 
(Besag, Green, Higdon, & Mengersen, 1995).  For a comprehensive treatment of MCMC 
methods, see (Robert & Casella, 2004) 
The model selection criteria employed, especially BIC, tend to detect a lower 
number of join points compared with AIC or the permutation tests approach.  To detect 
the accuracy of those models it would be useful to compare their estimates with those 
resulting from the standard survival models. 
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CHAPTER 5: TRENDS IN BRAIN TUMOR INCIDENCE RATES IN USA 
 
The study aims to update information and provide a sufficiently detailed 
perspective on the epidemiology of primary brain tumors in the USA for different age 
groups, sexes, races, finally, both overall and for different histologies using the data at 
hand.  To this end, we employ descriptive and analytical methods to characterize the 
incidence of brain tumors.  The National Cancer Institute’s Surveillance, Epidemiology 
and End Results (SEER) program (www-seer.ims.nci.nih.gov) provides information and 
other comprehensive recourses with regard to incidence, mortality, and survival on 
tumors from various U.S. metropolitan areas and states collected since 1973.  We present 
the analysis in three sections, the first one introductory, and each of the following two 
sections referring to similar but different aspects of essentially the same data obtained 
from SEER. 
 
5.1 Introduction 
 
The histological site groups have been based on the classification scheme 
proposed by R.D. Barr in 2006 presented schematically in Figure 1, are employed for 
more detailed analysis of the information in terms of specific histological subgroups. 
Astrocytoma, subdivided in Specified low grade astrocytic tumor, Glioblastoma and 
anaplastic astrocytomas, Astrocytoma non-otherwise specified (NOS). Other glioma, 
 61 
Ependymoma, Medulloblastoma and other Primitive Neuroectodermal Tumors (PNET) 
subdivided in Medulloblastoma, Supratentorial PNET.  Finally, Other specified 
intracranial and intraspinal neoplasms, Unspecified intracranial and intraspinal neoplasms 
subdivided in Unspecified malignant intracranial and intra spinal neoplasm and 
Unspecified benign/boarder intracranial and intraspinal neoplasms. 
 
Figure 5.1 Classification scheme for tumors of the brain and the central nervous 
system. 
The classification scheme put in use, was proposed by RD Barr and his colleagues.  The variables were 
updated from the original ICD-O-2 based classification scheme using ICD-O-3 definitions for cancer 
morphology and topography. 
 
5.2 Tumor records include size information (Part I). 
 
For the first part of the analysis we have selected data on malignant primary brain 
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tumors diagnosed from 1973 through 2006 which are available for the following 
registries: Atlanta, Connecticut, Detroit, Hawaii, Iowa, New Mexico, San Francisco-
Oakland, Seattle-Puget Sound, and Utah, Los Angeles, San Jose-Monterey, Rural 
Georgia, and the Alaska Native Tumor Registry, Greater California, Kentucky, 
Louisiana, and New Jersey, representing approximately 28% of the US population.  The 
data set includes 72,770 primary malignant brain tumor cases: 37,150 males and 35,620 
females.  Out of those, 11,331 male and 11,027 female cases include records for tumors’ 
size, which we averaged for individuals with the same age at diagnosis in the plot below.  
Evidently, average sizes of tumors diagnosed before 45 years of age exhibit greater 
variability than those tumors diagnosed later. 
For the first part of the analysis we have selected data on malignant primary brain 
tumors diagnosed from 1973 through 2006 which are available for the following 
registries: Atlanta, Connecticut, Detroit, Hawaii, Iowa, New Mexico, San Francisco-
Oakland, Seattle-Puget Sound, and Utah, Los Angeles, San Jose-Monterey, Rural 
Georgia, and the Alaska Native Tumor Registry, Greater California, Kentucky, 
Louisiana, and New Jersey, representing approximately 28% of the US population.  The 
data set includes 72,770 primary malignant brain tumor cases: 37,150 males and 35,620 
females.  Out of those, 11,331 male and 11,027 female cases include records for tumors’ 
size, which we averaged for individuals with the same age at diagnosis in the plot below.  
Evidently, average sizes of tumors diagnosed before 45 years of age exhibit greater 
variability than those tumors diagnosed later, as can be shown clearly in Figure 5.2 where 
the average tumor size diagnosed for all ages is plotted against the age at diagnosis. 
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Figure 5.2 Average size of diagnosed tumors, SEER. 
Average tumor size (the largest dimension or diameter of the primary tumor in mm) plotted against age at 
diagnosis for tumors diagnosed from 1973-2006 that are included in the SEER 9 registries database. 
 
 The mean tumor sizes in Table 5.1 include number of patients, in parentheses, 
diagnosed with malignant brain tumors between 1969 and 2006 for different age groups 
and gender.  The mean tumor size of male is larger than the mean tumor size of female 
(p-value < 0.00005).  When testing the same hypothesis within different races we failed 
to reject in all the cases (white, black and other), comparisons of the mean tumor sizes 
between male and female patients at the same age group and same histology type: for 
Medulloblastic tumors the mean sizes do not differ between males and females for all the 
age groups.  In all other comparisons the null hypothesis was rejected for the adult and 
elder groups with the exception of the unspecified tumors diagnosed in adult patients.  
Data are further analyzed with respect to the following three major age groups, 0-19, 20-
64, 65+. 
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About 9.4% of the tumors occurred in children (0-19 years old), whereas the 
majority of 46.3% were in the 20 to 64 year old group, with the remaining 43.9% 
occurring in the elderly (65 years or older).  The vast majority of people in the data set 
were white (87.3%).  
 
Table 5.1 Average tumor size by gender and age, SEER. 
Average tumor sizes (in mm) by major histological type for primary brain tumors across different age 
groups (with corresponding number of diagnosed cases in italics). 
 
 Age Groups (Males) Age Groups (Females) 
Histology 0-19 20-64 65+ 0-19 20-64 65+ 
Astrocytoma 43.35 (704) 
43.36 
(3328) 
42.91 
(2096) 
42.59 
(428) 
39.75 
(2824) 
38.22 
(2305) 
Other Glioma 42.27 (222) 
44.37 
(867) 
45.17 
(562) 
46.42 
(168) 
42.67 
(617) 
40.69 
(605) 
Ependymoma 41.35 (23) 
41.91 
(257) 
41.56 
(130) 
39.56 
(18) 
35.95 
(326) 
28.11 
(307) 
Medulloblastoma 43.86 (70) 
46.69 
(287) 
79.44 
(284) 
40.70 
(47) 
48.72 
(176) 
46.04 
(141) 
Other Specified 41.19 (88) 
40.93 
(616) 
44.66 
(494) 
41.83 
(88) 
32.66 
(808) 
32.85 
(550) 
Unspecified 42.41 (122) 
40.62 
(788) 
41.00 
(351) 
36.35 
(75) 
38.63 
(544) 
39.74 
(544) 
 
In Table 5.2 we summarize malignant brain tumors occurrences by gender for 10 
individual histology groups during the 1973-2006 period.  The increased incidence of 
Ependymomas in females is suggestive of this trend in the female population being of 
etiologic importance.  Because all of these groups are not mutually exclusive, the total 
number of incidences will not match the sum of incidences.  An artificial decrease in 
brain tumor incidences of the NOS type may have been occurring due to wider 
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availability of accurate diagnostic tools, thus any evaluation of trends for this histology 
type would be unsafe. 
 
Table 5.2 Diagnosed tumors distributed by gender. 
The data set includes 72,770 primary malignant brain tumor cases: 37,150 males and 35,620 females.  Out 
of those 11,331 males cases and 11,027 females include records for tumor size. 
Groups         Number of cases 
      Male            Female 
Astrocytoma   
Specified low grade astrocytic tumor 3375 3183 
Glioblastoma and anaplastic astrocytoma 12226 11255 
Astrocytoma NOS 4386 4045 
Other Glioma       4135 3715 
Ependynoma 691 1040 
Medulloblastoma and other Primitive Neuroectodermal Tumors   
Medulloblastoma 47 39 
Supratentorial PNET 916 791 
Other specified intracranial and intraspinal neoplasms 6405 6761 
Unspecified intracranial and intraspinal neoplasms   
Unspecified malignant  intracranial intraspinal neoplasm 6449 2112 
Unspecified benign  intracranial intraspinal neoplasm 6752 5126 
 
Further information for the number of diagnosed tumors by age and race/gender is 
tabulated below; cases are classified racially as white or nonwhite.  Age distributions 
differ by histology type suggesting different etiologic factors are active. Specific 
histologies that were increasing were lymphomas in individuals aged 20 to 64 years and 
in males aged 65 years or older, ependymomas in the population aged 20 to 64 years, 
nerve sheath tumors in males, and pituitary tumors in females.  Increases that were not 
specific to any population subgroup were seen for glioblastoma, oligodendrogliomas, and 
astrocytomas, excluding not otherwise specified (NOS) tumors. Corresponding decreases 
were noted for NOS, astrocytoma NOS, and glioma NOS. 
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Table 5.3 A more detailed histological classification. 
Characteristics of the study population by histology  type, race, sex.  The sums of the subgroups listed do 
not equal the total, tumor types included in the total may not be in a specific subgroup of SEER 
classification.  All numbers in the body of the table are percentages, except at the Total column. 
  Age category Race/Gender  
Histology 0-19 20-64 65+ White male 
Non-
white 
male 
White 
female 
Total 
Astrocytoma        
Specified low grade astrocytic tumor 9.1 43.8 46.9 45.3 6.2 42.3 6558 
Glioblastoma and anaplastic astrocytoma 9.6 47.0 43.3 46.6 5.6 42.9 23661 
Astrocytoma NOS 9.8 43.6 46.5 42.8 9.2 37.9 8431 
Other Glioma 10.0 43.6 45.8 45.4 7.2 40.8 7856 
Ependynoma 5.8 52.1 42.0 30.9 9 43.8 1731 
Medulloblastoma and other Primitive Neuroectodermal 
Tumors (PNET)        
Medulloblastoma 69.7 26.7 3.4 48.8 3.5 36 86 
Supratentorial PNET 6.5 45.2 48.2 50.4 3.2 43.5 1707 
Other specified intracranial and intraspinal neoplasms 9.0 51.7 39.2 37.4 7.9 40.8 9901 
Unspecified intracranial and intraspinal neoplasms        
Unspecified malignant intracranial intraspinal 
neoplasms 11.7 52.3 35.9 50.4 4.2 41.8 11792 
Unspecified benign intracranial intraspinal neoplasm 3.1 58.3 38.5 30.8 4.9 57.5 961 
Total 9.3 46.3 43.8 44.8 6.2 42.5 72770 
 
5.3 Tumor records do not include size information (Part II). 
 
Between 1973 and 2006, 49,531 cases of malignant brain tumors were diagnosed 
in the USA nine SEER registries and recorded in the data released in April 2009.  The 
resulting incidence rate is 6.9 cases per 100,000 person-years for whites.  The most 
common histology has been Astrocytoma with 32,103 cases diagnosed resulting in 5 
cases per 100,000 person-years, followed by Other gliomas with 6,724 cases resulting in 
1 case per 100,000 person-years.  Less common histology types have been Unspecified 
intracranial and intraspinal neoplasms, Medulloblastoma and other Primitive 
Neuroectodermal Tumors (PNET), Ependymoma, Other specified intracranial and 
intraspinal neoplasms with 1,610, 1,505, 1,382, 1,004 cases, respectively. 
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The resulting incidence rates are 3.3 and 3.0 cases per 100,000 person-years for 
all brain tumors in Blacks and American Indian/Alaska native, Asian/Pacific islanders, 
respectively.  The most common histology has been Astrocytoma with 1,821 and 1,302 
cases diagnosed resulting in 2.0 and 1.8 cases per 100,000 person-years, respectively.  
The next most common histology type has been Other glioma with 0.6 cases per 100,000 
person-years (493 and 418 cases in the 34 year period, respectively) for both remaining 
racial groups.  The next most common histology types for Blacks were Medulloblastoma, 
Other specified and Unspecified with 173, 174, 142 cases, respectively, resulting in 0.2 
cases per 100,000 person-years.  Finally, the least common histology type has been 
Ependymoma with 0.1 cases per 100,000 person-years.  Medulloblastoma is the third 
most common histology type for the American Indian/Alaska native, Asian/Pacific 
islander racial group with 0.2 cases per 100,000 person-years (157 cases).  Lastly, 
Unspecified, Ependymoma, and Other specified with 75, 94, 92, cases, respectively, 
resulting in 0.1 cases per 100,000 person-years, as can be seen below. 
 
Table 5.4 Brain tumor incidence rates by race. 
Incidence rates per 100,000 person-years and number of brain tumor incidences for major histology types 
by racial groups. 
 White Black Other 
 Incidence 
rate 
No. of 
cases 
Incidence 
rate 
No. of 
cases 
Incidence 
rate 
No. of 
cases 
Astrocytoma 5 32,103 2.0 1,821 1.8 1,302 
Other glioma 1 6,724 0.6 493 0.6 418 
Ependymoma 0.2 1,382 0.1 127 0.1 94 
Medulloblastoma 0.2 1,505 0.2 173 0.2 157 
Other specified 0.2 1,004 0.2 174 0.1 92 
Unspecified 0.2 1,610 0.2 142 0.1 75 
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In Figure 5.3 we display race specific incidence rates of brain tumors.  The most 
common histologically confirmed tumor type, Astrocytoma, has been much more 
frequent in White populations than any other tumor type, while this relationship is 
roughly inverted for Unspecified intracranial and intraspinal neoplasms, Other specified 
intracranial and intraspinal neoplasms, Medulloblastoma and other Primitive 
Neuroectodermal Tumors and Ependymomas.  For the rest of this report we will be 
referring to those major histology groups as follows:  Medulloblastoma and other 
Primitive Neuroectodermal as Medulloblastoma, Other specified intracranial and 
intraspinal neoplasms as Other specified, and Unspecified intracranial and intraspinal 
neoplasms as Unspecified. 
 
 
Figure 5.3 Histology distribution by race. 
Incidence rates among different racial groups calculated include those for Black, and American 
Indian/Alaska native, Asian/Pacific islander populations.  The SEER datasets include one more racial 
group, which includes information only after 1991, namely other unspecified.  Since the information for 
that group is very sparse, we decided not to include this racial group in our analysis.  
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Incidence rates among different racial groups calculated include those for Black, 
and American Indian/Alaska native, Asian/Pacific islander populations.  The SEER 
datasets include one more racial group, which includes information only after 1991, 
namely other unspecified.  Since the information for that group is very sparse, we decided 
not to include this racial group in that part of the analysis. 
Surely, some of the variation exhibited in incidence rates for different sexes and 
histology types reflects improvements in diagnostic practices around the 1973-2006 
period.  Nevertheless, we computed annual percent change (APC) using weighted least 
squares methods for the data of interest and note with a star those changes that are 
significant at the 0.05 level.  We report for Specified low-grade astrocytic tumors the 
Annual Percent Changes (APC) were 1.1 for males, and 1.6%* for both sexes.  
Glioblastoma and anaplastic astrocytoma rates have been changing by 1.7%*, 1.9%* and 
1.8%*, respectively.  Astrocytoma non-otherwise specified incidence rates had been 
changing by -3.7%*, -3.2%* and -3.5%* each year for males females and both sexes 
respectively, possibly reflecting an improvement in diagnostic methods.  Other glioma 
incidence rates have been increasing by 1.7%*, 1.5%* and 1.6%* respectively during the 
period, while Ependymomas by 0.9%*, 1.2%* and 1.2%*.  Conversely, Medulloblastoma 
rates have been decreasing by 1.7%* for males, while increasing by 0.4% for females 
(APC is -0.9% for both sexes).  Other specified exhibited increasing rates by 1.5%, 
3.2%*, and 2.3%* respectively.  Finally, Unspecified have been increasing yearly by 
0.1%, 0.4%, and 0.3% respectively.  In Figure 5.5 we trace the incidence rates for both 
male and female patients for various histological types for the 1973-2006 period. 
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Figure 5.4 Symbols for different histologies used on the chapter plots. 
The different histology classes with their respective symbols used for  presentation reasons throughout the 
present Chapter. 
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Figure 5.5 Histology distribution by gender. 
Incidence rates of primary brain tumors for males (left) and females (right) by histological types, SEER 
data, 1973-2006.  The degree of smoothness for the plotted curves depends on the age information and the 
curves will be increased in Figure 5.6 in order to facilitate trends interpretation. 
 
For young (age 0-19) patients diagnosed with astrocytoma the incidence peaks at 
age 2-4 years for both sexes.  Conversely, Other glioma and Ependymoma for young 
males do not exhibit any clear peak.  We should note down a difference between sexes in 
Ependymoma incidence: the specific diagnosis in males is likely to occur earlier than in 
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females and the converse is true for Medulloblastoma.  The average age at diagnosis with 
Medulloblastoma is higher for young males than young females (p<0.05).  For the 
malignant intracranial and intraspinal neoplasms, benign/border intracranial and 
intraspinal neoplasms we noticed a divergence in the age distribution, specifically, there 
is a higher number of male than female teenagers diagnosed with the specific histology. 
For adults (age 20-64) diagnosed with Astrocytoma the incidence peaks at age 57-59 
years for both sexes, as can be shown in Figure 5.5.  Another interesting feature of the 
adult female age distribution diagnosed with Other glioma is a peak at the age of 54.  
  Examination of age at diagnosis for the adult groups showed similar for both 
sexes.  Nevertheless, the distribution of age at diagnosis with Other glioma for males 
exhibited greater skewness to the left than the corresponding female category.  For 
example, Other gliomas incidence rates for whites are 1.4 times larger in males than 
females, and this ratio is maintained for non-white males and females.  We also note that 
the sex differential (greater incidence in males) in glioblastoma and anaplastic 
astrocytoma is 1.6.  We plotted the differences between male and female incidence rates 
to see the sex differential began to evident around the age of 25, was greatest around the 
age of 75, and decreased thereafter, though the same data for non-white population did 
not exhibit the same degree of smoothness. 
In addition, cases diagnosed with Astrocytoma for nonwhite males (lower right) 
exhibit different variation of incidence rates after 40 years of age. The incidence rate 
exhibits low variability later than the age of 72 for nonwhite whereas there is a sharp 
decrease in the three remaining groups. 
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Figure 5.6 Incidence rates of primary brain tumors by gender and histological 
types, SEER. 
Incidence rates of primary brain tumors for white females and males (upper left and right) and non-white 
females and males (lower left and right) by histological types, SEER data, 1973-2006.  Notice that we did 
not preserve the same scale for the y-axes of the graphs. 
 
We can roughly distinguish between three behavioral groups in terms of 
distribution of incidence rates at different ages at diagnosis.  The first one comprising 
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Glioblastoma and anaplastic astrocytoma, the incidence rates sharply peak at the age 
group with midpoint 32 years for all four clusters of the population of interest.  In 
contrast, the incidence rates remain fairly stable for all the age groups in the case of 
Specified low-grade astrocytic tumors, Medulloblastoma, Other specified intracranial and 
intraspinal neoplasms, Unspecified malignant intracranial/spinal neoplasms, Unspecified 
benign/border intracranial/spinal neoplasms. Lastly, we point out that considerable 
variability can be seen, especially after the age of 40 where a steady increase is 
prominent, in Astrocytic NOS tumors, Other gliomas, Supratentorial PNET’s diagnosed 
in all four subpopulations. We conclude this chapter with a brief concluding section.  
 
5.4 Discussion 
 
Interest in brain tumor trends was sparked largely by reports that mortality from 
cancer was increasing in industrialized nations (Davis et al., 1988,1991).  Indeed, brain 
tumor incidence was shown to have increased over time in children (McKinney et al., 
1994) as well as in the elderly as claimed by Polednak and Flannery in 1995, and has 
included both overall increases as well as histology specific increases.  An artificial 
increase in brain tumor incidence has occurred due to improvements in diagnostic 
technology, most notably with the widespread use of computerized tomography (CT) and 
magnetic resonance imaging (MRI) scans among others beginning in the last few 
decades.  These new and noninvasive diagnostic tools allow clinicians to identify 
previously undiagnosed brain tumors. 
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This analysis represents an updated U.S. study of brain tumor incidence trends to 
include all primary brain tumors, regardless of histology.  This inclusion allows for a 
more accurate analysis of trends in histologic subgroups that are of mixed behavior.  
Including all primary brain tumors from multiple regions also provided a sufficient 
number of tumors to examine trends in relatively rare histologic subgroups like 
oligodendrogliomas, and ependymomas.  A separate analysis of NOS categories provides 
indirect evidence for a shift in the precision of diagnoses with the new diagnostic 
procedures an issue we refer to in the next chapter. 
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CHAPTER 6: FUTURE WORK AND CONNECTIONS WITH EPIDEMIOLOGY 
 
This chapter stands on the foundations built on Chapters 4 and 5.  We make 
necessary connections between the methods employed in those chapters and report on 
ongoing work that could not be included in this thesis.  Finally, we emphasize the 
importance of the reported considerations that (importance) being both related to the 
issue of identification of changes in recent trends of diseases and the realization that the 
methods employed here can be used to examine epidemiological features from a variety 
of diseases including other types of cancer, as well as international variation of such 
diseases, provided the data is adequate for the purposes of the analysis.  The chapter is 
organized in one section. 
 
6.1 Connections to existing studies and further considerations 
 
 As reported in (Curado, Edwards, & Shin, 2007) in the report named “Cancer 
Incidence in Five Continents, Volume IX (CI5-IX)”, age standardized rates for malignant 
neoplasms of the brain and the central nervous system varied three to fourfold among 
both sexes for the 1998-2002 period in populations around the world.  In short, rates were 
highest in Northern America, Europe and Australia and lowest in Asia and Africa.  
International variation for other types of cancer and comparison of patterns observed with 
other types of cancers has been studied in (Parkin, Pisani, & Ferlay, 1999) and review of 
the  literature published by (Inskip, Linet, & Heineman, 1995), more recently (Wrensch, 
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Minn, Chew, Bondy, & Berger, 2002) elaborate on the impact of enviromental factors 
and lifestyle on related incidence rates. 
While it is so far undisputable, to our knowledge, that the difference in incidence 
rates among males and females is biologically based, there are published results 
suggesting that different populations (we refer to the term population with its 
genetic/geographic connotation here) have substansially lower brain tumors incidence 
rates.  In particular, genetic differences between racial/ethnic groups are believed to 
account for lower rates in southeastern Asian origin populations; regardess of residence 
consistently lower brain tumors incidence rates have been observed than white 
populations, suggesting that this racial difference is biologically based (McCredie, 1998).  
On the other hand there have been reports (Parkin, Bray, Ferlay, & Pisani, 2005) which 
account most of the international variation in cancer incidence rates into enviromental 
rather than genetic determinants of cacncer on the population level. 
Investigators have been reluctant to draw conclusions about differences in 
population incidence rates, concerned about the inconsistencies among cacner registries 
in reporting and coding standards and differences in diagnostic capabilities and medical 
care in general.  In their reports (Fisher, Schwartzbaum, Wrench, & Wiemels, 2007), 
(Ohgaki & P., 2005) and (Preston-Martin, Munir, & Chakrabarti, 2006) stress that all or 
part of the observed differences among racial groups can be due to different exclusion 
and inclusion criteria for different registries and populations.  Lately,  there have been 
publications (Darefsky & Dubrow, 2009) aiming to establish a uniform platform on data 
inclusion/exclusion criteria in order to make direct comparisons between datasets 
obtained from various international registries. 
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We identified populations from registries in the USA that meet quality criteria 
especially for primary malignant tumors of the brain and central nervous system and 
found that, in accordance with relevant literature, within the populations of study females 
are less likely to be diagnosed with any kind of tumor of the brain and the central nervous 
system.  We have also found out that incidence rates within different histologies vary 
considerably for different age groups and most importantly among racial groups.  We 
have been very careful in making any conlusions regarding racial differences in the 
estimates risks for a variety of reasons.  Analogous indices, not infrequently named 
person years, are frequently calculated in therapeutic and epidemiological studies.  It is 
the view of the writer that the use of this type of index should be neither universal, nor 
without attention to the particular circumstances. 
In particular, the estimate of the risk involved when this is derived with the use of 
the person year incidence rate in a sample of individuals, is apropriate, therefore 
comparisons between such measures are also valid, when the individuals can be assumed 
to experience constant and equal risks (Sheps, 1966).  Therefore, when performing any 
comparisons of the risks involved in different racial groups interest should be directed in 
the changes occuring in the indices by increasing the duration of observation, or even the 
number of people constituting the registry.  The effects of heterogeneity among 
individuals can lead to increased bias for the indices, for example unequal probabilities of 
withdrawals for different individuals.  It seems that it would be desirable to employ 
alternative methods to measure the risks involved with fundamentally different 
populations, where intuitively the previous assumptions seem unrealistic.  The actuarial 
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or life table method of measuring risks will be also used to make crucial investigations 
about observed differences in rates between distinct populations. 
Similarly, comparisons of incidence rates between different registries will be 
made in order to investigate possible enviromental factors that could effect the disease 
risk, if registry specific incidence rates tend to be homogeneous across different 
histologies, justification will be provided for collapsing the geography-level populations 
of the same broad racial group.  We remind the reader that the population characteristics 
related to race/ethnicity vary considerably for the registries of our study.  For example in 
the San Francisco-Oakland registry the percentage of non-Hispanic white is considerably 
smaller than that percentage in the Utah registry according to the US census bureau. 
This type of heterogeneity with regard to the ethnic characteristics of various 
registries leads us to the following working model: for general comparison purposes the 
most balanced design better suited to test for interactions between race/ethnicity and 
various other data attributes is the one classifying any individual as white or non-white.  
In this thesis, we attempted to address this effect in Section 5.3 where we compared 9 
incidence rates corresponding to various histology types for males/female individuals that 
are white and males/females that are not classified as white.  To make this determination 
and to attempt to address the balance concern, we consulted a variety of sources, 
including the USA census bureau, it is claimed that the 2020 will be the first census 
where the number of whites in the population will be roughly equal to the number of non-
whites. 
The behavior of several phenomena has been studied through mathematical and 
statistical models.  It is the intention of the writer to continue working on the above-
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mentioned problems and in circumstances where it may be reasonable to assume 
homogeneity in the risk assumed by individuals proceed with the analysis as it has been 
conducted so far.  However, for the findings reported in this thesis it is suggested that, 
either when based on different studies or based on assumptions that may be subject to 
some question, investigators may find it necessary to re-evaluate the data on which such 
conclusions have been based. 
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